For research use only
| Cat No. | ABC-SC2058 |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Choroideremia |
| Storage | Liquid Nitrogen |
Cell Type: iPSC; Disease: Choroideremia; CHM CHM GENE; CHM.
HighQC™ Human IPSC From Fibroblast-Choroideremia is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with Choroideremia, an X-linked recessive chorioretinal dystrophy caused by mutations in the CHM gene. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They maintain pluripotency and reflect CHM-related retinal traits. These cells retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HighQC™ Human IPSC From Fibroblast-Choroideremia, HighQC™ hiPSC CHM, hiPSC-CHM, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Choroideremia |
| Species | Human |
| Cat.No | ABC-SC2058 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Fibroblast |
| Disease | Choroideremia |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
| Gene Info | Gene: CHN |
HighQC™ Human IPSC From Fibroblast-Choroideremia provides a patient-specific model for ocular developmental and disease research. Its pluripotent capacity enables differentiation into retinal pigment epithelium (RPE) cells and photoreceptor precursors, key lineages affected by CHM gene mutations. This system is used to model retinal degeneration, study choroid and RPE development, and perform high-throughput compound screening in retinal organoids for potential therapeutic strategies targeting this inherited retinal disease.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).